期刊文献+

应用E-test法、肉汤微量稀释棋盘法检测泛耐药鲍曼不动杆菌的试验 被引量:4

Combined anfimicrobial susceptibility test against pan-drug-resistant Acinetobacter baumannii with E-test and microdilution checkerboard assay
原文传递
导出
摘要 目的比较E-test法和肉汤微量稀释棋盘法(CB法)检测体外联合药敏试验并与时间杀菌曲线对比的观察。方法选择31株泛耐药(PDR)鲍曼不动杆菌临床株进行体外试验,分为替加环素、可立其丁、亚胺培南、阿米卡星单用和两药组合,亚胺培南+替加环素+阿米卡星三药组合也由CB法测试。这些测试的结果与时间杀菌曲线进行比较。结果亚胺培南+可立其丁、替加环素+亚胺培南能检测到协同作用。培养基中加入抗菌药物的E—test法联合药敏试验与时间杀菌曲线更具有可比性。在三药组合中由CB法和时间杀菌曲线可以检测到协同作用。结论结果表明联合药敏试验中协同作用测试可以预测特定的抗生素组合对泛耐药鲍曼不动杆菌的作用。 Objective To evaluate the activity of antibiotics against pan-drug-resistant (PDR) Acinetobacter baumannii by combination antimicrobial susceptibility test in viro with epsilometric methods ( E- test method) and microdilution checkerboard (CB method), and to detect a good correlation between time- kill curve with the above mentioned two assays. Methods Thirty-one clinical isolates of PDR Acinetobacter baumannii were selected for mono and combination antimicrobial susceptibility test in vitro by E-test and CB method, then a comparison was conducted between the test results and the time-kill curve. Mono drugs in- volved tigecycline, colistin, imipenem and amikacin, and combinations involved two of drugs above, and three drugs involved imipenem/tigecycline, plus amikacin combination. Results Synergistic effect was de- tected in imipenem plus colistin and tigecycline plus imipenem combination. A high comparability was re- vealed between the E-test method with antimicrubial drugs added into the culture medium and the time-kill curves. Synergy in the combination of imipenem/tigecyeline, plus amikacin was detected by the CB method and time-kill curves. Conclusion The results showed that the effect of specific combination of antibiotics against PDR Acinetobacter baumannii could be predicted by testing their synergistic effect with combination antimicrobial susceptibility test.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2013年第2期144-147,共4页 Chinese Journal of Microbiology and Immunology
关键词 E—test法 肉汤微量稀释棋盘法 时间杀菌曲线 泛耐药鲍曼不动杆菌 E-test method Broth microdilution checkerboard method Time-kill curve Pan-drugresistant Acinetobacter baumannii
  • 相关文献

参考文献11

  • 1Foumier PE, Richet H. The epidemiology and control of Acineto- bacter baumannii in health care facilities. Clin Infect Dis, 2006, 42(5) : 692-699.
  • 2Sehafer JJ, Goff DA, Stevenson KB, et el. Early experience with tigecyeline for ventilator-associated pneumonia and baeteremia eansed by multidrag-resistant Acinetobacter baumannii. Pharmaco- therapy, 2007, 27 (7) : 980-987.
  • 3Clinical and Laboratory Standards Institute. MI1-S21: Perform- ante standards for antimicrobial susceptibility testing: Twenty- First informational supplement. Wayne, Pa: Clinical and Labora- tory Standards Institute, 2011.
  • 4Wareham DW, Bean DC. In vitro activity of polymyxin B in com- bination with imipenem, rifampiein and azithromycin versus multi- drug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases. Ann Clin Micrebiol Antimicrob, 2006, 5: 10.
  • 5Scheetz MH, Qi C, Warren JR, et el. In vitro activities of various antimicrebials alone and in combination with tigecycline against or -resistant Acinetobaeter baumannK Antimicrob Agents Chemother, 2007, 51 (5) : 1621-1626.
  • 6Petersen PJ, Labthavikul P, Jones CH, et el. In vitro antibacterial activities of tigecycline in combination with other antimierebial agents determined by chequerboard and time-kill kinetic analysis. J Antimicrob Chemother, 2006, 57(3): 573-576.
  • 7Durante-Mangoni E, Zarrilli R. Global spread of drug-resistant Acinetobacter baumannii : molecular epidemiology and management of antimicrebial resistance. Future Microbiol, 2011, 6(4): 407- 422.
  • 8王铁山,苏建荣.不同抗菌药物组合对多重耐药鲍曼不动杆菌的作用研究[J].中华微生物学和免疫学杂志,2011,31(10):898-902. 被引量:13
  • 9van Ogtrop ML, Andes D, Stamstad TJ, et al. In vivo pharmaco- dynamic activities of two glycylcyclines ( GAR-936 and WAY 152, 288) against various gram-positive and gram-negative bacteria. Antimicrob Agents Chemother, 2000, 44 (4) : 943-949.
  • 10Moffatt JH, Harper M, Harrison P, et 81. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopo- lysaccharide production. Antimicrob Agents Chemother, 2010, 54 (12) : 4971-4977.

二级参考文献43

  • 1Marchand L, Damier-Patrice L, Courvalin P, et al. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component syste. Antimicrob Agents Chemother, 2004, 48(9): 3298-3304.
  • 2National Bureau of Standards. Data Encryption Standard. U.S. Department of Commerce, FIPS Pub., 1977-01
  • 3Biham E, Shamir A. Differential Cryptanalysis of DES-like Cryptosystems. Advances in Cryptology-crypto '90 Proceedings, Springer-verlag,Berlin Heidelberg, 1991
  • 4Wiener M J. Efficient DES Key Search, TR-224. School of Computer Science, Carleton University, 1994-05
  • 5Lai X. On the Design and Security of Block Ciphers. ETH Series in Information Processing(I). Hartung-gorrc Verlag, Konstanz, 1992
  • 6Joan D, Govaerts R, Vandewalle J. Weak Keys for IDEA. Crypto 1993:224-231
  • 7Peleg AY, Seifert H, Paterson DLAeinetobaeter baumannii: emergence of a successful pathogen. Clin Micmbiol Rev,2008,21 : 538-582.
  • 8Falagas ME, Koletsi PK, Bliziotis IA.The diversity of definitions of muhidrug-resistant(MDR) and pandrug-resistant (PDR) Aeinetohaeter bsumannli and Pseudomonas aeruginosa.J Med Microbiol, 2006,55: 1619-1629.
  • 9Paterson DL, Doi Y.A step closer to extreme drug resistance(XDR) in gram-negative bacilli.Clin Infect Dis,2007,45: 1179-1181.
  • 10Falagas ME, Karageorgopoulos DE.Pandrug resistance(PDR), extensive drug resistance(XDR), and muhidrug resistance(MDR) among Gram- negative bacilli: need for international harmonization in terminology.Clin Infect Dis, 2008,46: 1121-1122; author reply 1122.

共引文献512

同被引文献27

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部